Completed PHASE1 INTERVENTIONAL NCT00213057

Safety and Acceptability of Carraguard™ Among HIV-negative Couples in Thailand

A Randomized, Placebo-controlled, Double-blind Trial to Assess Expanded Safety and Acceptability of Carraguard™ (PC-515) Vaginal Gel Among Heterosexual Couples in Chiang Rai

Sponsor: Bill and Melinda Gates Foundation

Conditions Chlamydia Trachomatis HIV Infections Nesseria Gonorrhea Syphilis Trichomonas Vaginitis

Interventions Carraguard (PC-515)

Updated 6 times since 2017 Last updated: Aug 11, 2017 Started: Jun 30, 2001 Completion: Jun 30, 2002

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1 trial investigates Chlamydia Trachomatis and HIV Infections and is currently completed. Bill and Melinda Gates Foundation leads this study, which shows 6 recorded versions since 2001 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Jun 2018 — Jan 2021 [monthly]

Completed PHASE1
Sep 2017 — Jun 2018 [monthly]

Completed PHASE1

▶ Show 1 earlier version

Jan 2017 — Sep 2017 [monthly]

Completed PHASE1

First recorded

Jun 2001

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Bill and Melinda Gates Foundation
Centers for Disease Control and Prevention
Chiang Rai District Health Office
Chiang Rai Hospital
Chiang Rai Municipal Health Office
Chiang Rai Public Health Office
Ministry of Health, Thailand
Population Council

Data source: Population Council

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Chiang Rai, Thailand